CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-06 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-05-06 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-05-06 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-05-06 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-05-06 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2020-02-10 | SCHIMMEL PAUL Director | Purchase | +254,000 | $4.25 | $1.1M | 437,590 |
| 2020-02-07 | Shukla Sanjay President and CEO | Sale | −745 | $4.03 | $3K | 1,291 |
| 2020-02-07 | Broadfoot Jill Marie Chief Financial Officer | Sale | −375 | $4.03 | $2K | 7,125 |
| 2020-02-06 | Shukla Sanjay President and CEO | Option exercise | +1,786 | 2,036 | ||
| 2020-02-06 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −1,786 | 1,786 | ||
| 2020-02-06 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +893 | 7,500 | ||
| 2020-02-06 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −893 | 893 | ||
| 2020-02-05 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +39,327 | 39,327 | ||
| 2020-02-05 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +13,778 | 13,778 | ||
| 2020-02-05 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +23,359 | 23,359 | ||
| 2019-06-28 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +2,285 | 2,285 | ||
| 2019-06-28 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +2,285 | 2,285 | ||
| 2019-05-17 | Krueger Nancy General Counsel | Sale | −4,651 | $0.45 | $2K | 25,348 |
| 2019-05-16 | Krueger Nancy General Counsel | Option exercise | +12,500 | 29,999 | ||
| 2019-05-16 | Krueger Nancy General Counsel | Option exercise · Restricted Stock Units | −12,500 | 12,500 |
Page 9 of 15 · 284 trades